Parkinson's disease (PD) is the second most common progressive neurodegenerative
disease, affecting 1–2% of people over 65. The classic motor symptoms of PD result from …

Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, classically characterized by a triad of motor features: bradykinesia, rigidity and …

Parkinson's disease (PD) is a neurodegenerative condition which causes a characteristic
movement disorder secondary to loss of dopaminergic neurons in the substanitia nigra. The …

The characteristic and selective degeneration of a unique population of cells—the
nigrostriatal dopamine (DA) neurons—that occurs in Parkinson's disease (PD) has made the …

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder and is
characterized by a continuous and selective loss of dopaminergic neurons in the midbrain …

Parkinson's disease (PD) is currently the fastest growing disabling neurological disorder
worldwide, with motor and non-motor symptoms being its main clinical manifestations. The …

Curative therapies or treatments reversing the progression of Parkinson's disease (PD) have
attracted considerable interest in the last few decades. PD is characterized by the gradual …

Parkinson's disease (PD) is the second most frequent neurodegenerative disease after
Alzheimer's disease, which is characterized by a low level of dopamine being expressing in …

Parkinson's disease is a neurodegenerative disease affecting around 10 million people
worldwide. The death of dopaminergic neurons in the substantia nigra and the axonal fibers …

The classic motor deficits of Parkinson's disease are caused by degeneration of
dopaminergic neurons in the substantia nigra pars compacta, resulting in the loss of their …